Immunotherapy Follow-Up study launched for young cancer patients
NCT ID NCT05865301
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows up to 500 children and young adults (up to age 26) with B-cell leukemia or lymphoma who have received immunotherapy like Kymriah or blinatumomab. Researchers will use surveys and medical records to track survival, remission, and unmet needs. No new treatment is given; the goal is to learn more about long-term outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ann & Robert H. Lurie Children's Hospital of Chicago
RECRUITINGChicago, Illinois, 60611, United States
-
Atrium Health Levine Cancer Institute
RECRUITINGCharlotte, North Carolina, 28262, United States
-
Banner University Medical Center - Tucson
RECRUITINGTucson, Arizona, 85719, United States
-
Children's Hospital at Montefiore
RECRUITINGThe Bronx, New York, 10467, United States
-
Children's Hospital of Pittsburgh of UPMC
RECRUITINGPittsburgh, Pennsylvania, 15224, United States
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
-
City of Hope Comprehensive Cancer Center
RECRUITINGDuarte, California, 91010, United States
-
Cook Children's Medical Center
RECRUITINGFort Worth, Texas, 76104, United States
-
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital
RECRUITINGGrand Rapids, Michigan, 49503, United States
-
Dana-Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
-
Johns Hopkins All Children's Hospital
RECRUITINGSt. Petersburg, Florida, 33701, United States
-
Johns Hopkins University/Sidney Kimmel Cancer Center
RECRUITINGBaltimore, Maryland, 21231, United States
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
-
Nemours Children's Hospital
RECRUITINGNew Castle, Delaware, 19803, United States
-
OHSU Knight Cancer Institute
RECRUITINGPortland, Oregon, 97239, United States
-
Saint Jude Children's Research Hospital
RECRUITINGFairfax, Virginia, 22203, United States
-
Seattle Children's Hospital
RECRUITINGSeattle, Washington, 98105, United States
-
St. Louis Children's (Washington University)
RECRUITINGSt Louis, Missouri, 63110, United States
-
Stanford University
RECRUITINGPalo Alto, California, 94305, United States
-
UCSF (Benioff Children's)
RECRUITINGSan Francisco, California, 94115, United States
-
UT Southwestern/Simmons Cancer Center-Dallas
RECRUITINGDallas, Texas, 75235, United States
-
University of Florida Health Science Center - Gainesville
RECRUITINGGainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can antibody infusions outperform antibiotics in shielding CAR-T patients from infections?
- Could an ALS drug clear the fog of chemo brain?
- Engineered immune cells take aim at tough childhood leukemia
- Scientists build a biobank to crack the mystery of CAR-T cell failure
- Boosting CAR t cells: could a pill make lymphoma therapy more effective?
- Military study probes Toxins' role in lymphoma